Page last updated: 2024-10-29

1-methyl-3-isobutylxanthine and Retinitis Pigmentosa

1-methyl-3-isobutylxanthine has been researched along with Retinitis Pigmentosa in 1 studies

1-Methyl-3-isobutylxanthine: A potent cyclic nucleotide phosphodiesterase inhibitor; due to this action, the compound increases cyclic AMP and cyclic GMP in tissue and thereby activates CYCLIC NUCLEOTIDE-REGULATED PROTEIN KINASES
3-isobutyl-1-methylxanthine : An oxopurine that is xanthine which is substituted at positions 1 and 3 by methyl and isobutyl groups, respectively.

Retinitis Pigmentosa: Hereditary, progressive degeneration of the retina due to death of ROD PHOTORECEPTORS initially and subsequent death of CONE PHOTORECEPTORS. It is characterized by deposition of pigment in the retina.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Sandberg, MA1
Miller, S1
Berson, EL1

Other Studies

1 other study available for 1-methyl-3-isobutylxanthine and Retinitis Pigmentosa

ArticleYear
Rod electroretinograms in an elevated cyclic guanosine monophosphate-type human retinal degeneration. Comparison with retinitis pigmentosa.
    Investigative ophthalmology & visual science, 1990, Volume: 31, Issue:11

    Topics: 1-Methyl-3-isobutylxanthine; Adolescent; Adult; Animals; Cats; Child; Cyclic GMP; Electroretinograph

1990